MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202641079401 A) filed by Manipal Academy Of Higher Education on June 27, 2026, for Saliva-Based Lateral Flow Assay For Cancer And Hpv Screening, Method Of Manufacturing, And Uses Thereof.
Inventor includes Aman Pratap Singh.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure relates to a lateral flow assay-based detection system configured for non-invasive multiplex detection of biomarkers associated with early-stage oral cancer and high-risk Human Papillomavirus (HPV) infection selected from exosomal microRNAs, inflammatory cytokine, and high-risk HPV DNA. Said lateral flow assay-based detection system is designed for multiplex detection of biomarkers within a single platform, thereby eliminating the need for external sample preprocessing, laboratory infrastructure, or specialized clinical personnel.
Disclaimer: Curated by HT Syndication.
